I won't quibble with the above, as that too makes sense (and why would I? You've demonstrated you know what you're talking about on numerous threads). But how then to explain what Faded C is reporting re: the wildly successful quacks (my term, not FC's) in New York? It sounds like perhaps both arguments are true to some extent, depending on context?
I guess I'm always suspicious of the assumption that people (in this case patients/clients) make rational, well-informed decisions. And I know wealthy people who seek to acquire "the best" in a variety of areas of life, but I'm not convinced that the individuals I'm thinking about are actually smart enough to discern what "the best" is. I know a lotta folks with more money than brains.
To chime with regard to the recent posts, I thought it best to consider the following issue: Marketing in Clinical Psychology.
Generally speaking, clinical psychology does a poor job marketing itself as a field to the public at large. One of the reasons obscure, poorly researched, and ineffective treatments still continue to be practiced is because we have not found an effective way to inform consumers about what psychotherapy should entail, what forms of efficacious treatment exist, how they are purported to work, and how to find competent providers that offer them within the community.
Even when we do make attempts to inform the public, the message is not as accessible to consumers in comparison to pharmacotherapy. For example, "Take pill X, it works via neurotransmitter Y, leading to outcome Z in studies A, B, and C." While I realize that psychiatric medications and the practice of psychiatry is far more more complex than what I have just written, the complexities can be distilled into this type of message in order to be user friendly. Moreover, pharmaceutical companies have an enormous operating budget that can spread the word. Unfortunately, outcomes in therapy are much more difficult to explain and the evidence appears as less "scientific" and "compelling"to consumers. We also do not have a large operating budget to get the message out.
As a field, we need to consider how to market our "product" and explain the "why" and the "how" in a way that makes sense and is more digestible. What we do is valuable and can help better people's lives, and while we know that, no everyone does and/or believes it to be true. Keeping this in mind, I think the "product" we promote needs to be an empirically supported treatment. While I am biased in terms of my theoretical orientation and believe in evidence based practice, I am not sure that treatment approaches lacking efficacy studies will be well received by the community, if for no other reason than people will want to know that it has been well researched in comparison to medications. Not all approaches, despite their clinical usefulness, rich histories, and longstanding contributions to the field, have this form of support.
Taking this a step further, if we consider success of psychotherapists within this context, it makes perfectly logical sense that an individual who publishes books, seeks out certification by boards within the field (e.g., ABPP), and is able to explain how they are competent in ways that are easy to discern for the public (i.e., educational background, training at prestigious institutions, etc.), they will be more successful than those who do not have said credentials or savvy. If they can explicate how their treatment is effective, citing research in a way that is digestible to the average client, things look even better with respect to success as a professional.
To that end, I think being able to explain the "how" and "why" is critical and it is something our field needs to do on a large-scale basis and something all psychologists need to do on an individual basis in order to make a reasonable living. After all, none of us are in this for the money (i.e., wealth), if we were, we would not be doing it in the first place.